Indonesia Clinical Laboratory Market Outlook to 2026F (Second Edition)- Driven by Current Shortage, Widening Customer Base and Increasing Corporate Requirements For Clinical Testing
Published on
March 2022
Total pages
90
About the Report
About the Report
The report titled “Indonesia Clinical Laboratory Market Outlook to 2026F- Driven byCurrent Shortage, Widening Customer Base and Increasing Corporate Requirements For Clinical Testing” provides a comprehensive analysis of Clinical Laboratory Market in Indonesia. The report focuses on overall market size in terms of revenue generated by laboratories; Indonesia clinical laboratory market segmentation by Type of Independent Labs, type of payer, type of customers, types of tests, segmentation based on region and private hospitals. The report also covers the overall comparative landscape, trends and growth drivers, issues and challenge and government regulations. The report concludes with future projections and analyst recommendations highlighting the major opportunities and cautions.
Market Overview and SizeIndonesia Clinical Lab market was observed to grow with an augmenting growth rate in the review period 2016-2021. The Indonesia Clinical Lab market in terms of Revenue has increased at a positive CAGR of 11.5% during the review period 2016-2021. The growth was supported by increase in healthcare spending by aging population, expanding health insurance, growth in non-communicable disease and chronic diseases, rising disposable Income.
Market Segmentation of Data Center Industry
By Type of Labs: Clinical Laboratories can be recognized as Independent Labs, Private Hospital Labs and Public Hospital Labs. Public Hospital Labs have a majority in the Indonesian market followed by Private Hospital Labs.
By Number of Labs: The labs can be recognized as public or private labs basis their ownership. Private Labs dominate the market in Indonesia.
By Type of Private Independent Labs: In Indonesia, organized labs dominated the market share followed by unorganized labs. Majority of the organized labs are located in Java and Jakarta. This has been facilitated by increase in expenditure on health services, as people have become more health conscious.
By Type of Payer: Corporates have accounted for the largest share of the number of tests in Indonesia. As the growing Indonesian workforce has led to an increase in corporate clients for pre-employment checks and annual health checks, more companies are engaging with private medical labs.
By Type of Consumer (Basis Number of Tests): Majority of the patients who are consumer to these laboratories come through doctor referrals with majority market share based on the number of tests. Walk-ins and corporate clients respectively follow this.
By Type of Tests: On the basis of type of tests the market is split between Routine, Esoteric and Non-laboratory tests. The most popular in the market are Routine tests. The non-laboratory tests account for a relatively small share of lab tests due to the additional licenses required to carry them out. Thus, laboratories are reluctant to do those tests.
By Type of Routine Tests: The routine tests have different categories of tests. The leader in this category is CBC followed by Basic Metabolic Panel.
By Esoteric tests: The esoteric tests have different categories of tests. The leader in this category is endocrine followed by infectious disease.
By Region: Java, Jakarta and Bali have high rate of urbanization and more affluent population, which has created greater access and demand for private clinical laboratory testing services.
By Private Hospital Labs: Private hospitals either have their own in-house labs or have a tie-up with a third party lab to accommodate their labs. In Indonesia in-house laboratories have a majority.
Competitive Landscape
The market is highly concentrated with the top private independent players being Prodia and Diagnos. Market is dominated by Prodia (PRDA). Kimia farma is the 2nd major player and Bio medika is the least contributor. CITO was designated by the Ministry of Health to be one of the laboratories for examining the coronavirus. This helped to be recognized across the region and thereby sustain footprints in the market. To capture the shift, industry leaders have started to implement initiatives such as retailer partnering, offering home testing, and enhancing engagement with patients through digital presence.
Future Outlook and Projections
Over the forecast period 2022-2026F, the Indonesia Clinical Lab Market Revenue is further anticipated to increase by year 2026F, thus showcasing a CAGR of 12.5%. It is expected that the implementation of JKN will increase the demand for laboratory services. This will lead the public hospitals to refer samples to private independent laboratories for clinical testing, resulting in the growth of external referrals for private independent laboratories. Players, Investing to increase its testing capabilities and has adopted several advanced tests and technologies introduced in the global market, particularly specialized tests. Further, the major private independent laboratories chains are expected to undergo geographic expansion beyond key cities into underdeveloped areas. This will further lead to increase in market share in the overall Indonesia clinical laboratory market.
Key Segments Covered of Clinical Laboratory
- By Type of Labs
- Independent Labs
- Private Hospital Labs
- Public Hospital Labs
- By Number of Labs
- Private Labs
- Public Labs
- By Type of Private Independent Labs:
- Organised
- Unorganised
- By Type of payor:
- Corporates
- Out-Of-Pocket
- Private Insurance
- BPJS Badan Penyelenggara Jaminan Sosial (Social Insurance Administration Organization)
- By Type of Customer:
- Doctor Referral
- Corporates
- Walk-Ins
- External referrals
- Online Referrals
- By Type of Tests:
- Routine
- Esoteric
- Non-Laboratory
- By Type of routine tests:
- CBC
- Basic Metabolic Panel
- A1C
- Others
- ByType of Esoteric Tests
- Endocrine
- Infectious disease
- Allergic Disease
- Oncology
- Others
- By Private Hospital Labs
-
- In-HouseThird Party
- By Region
-
- Greater Jakarta
- West Java
- East Java, Bali, Nusa
- Aceh and North Sumatera
- Central Java
- Central Sumatera
- Sulawesi and Maluku
- Kalimantran
- Others
Key Target Audience
- Clinical Laboratory companies
- Organised Clinical Laboratories
- Unorganised Clinical Laboratories
- Private Hospitals
- Private Equity and Venture Capitalist
- Industry Associations
- Technology providers
Time Period Captured in the Report:
Historical Period – 2016-2021
Forecast Period – 2021-2026
Companies Covered:
Organised Laboratory Companies:
- Prodia
- Diagnos
- Pathlab
- Pramita
- Ultra Medica
- Kimia Farma
- Prima Medika
- Cito
- Parahita
- ABC Labs
- Bio Medika
Key Topics Covered in the Report
- Overview of Indonesia Clinical Laboratory Market
- Ecosystem of Major Entities in Indonesia Clinical Laboratory Market
- Business Cycle and Genesis of Indonesia Clinical Laboratory Market
- Indonesia Clinical Laboratory Market Size, 2016-2021
- Indonesia Clinical Laboratory Market Segmentations
- Competition Analysis: Indonesia Clinical Laboratory Companies
- SWOT Analysis in Indonesia Clinical Laboratory Market
- Growth Drivers and Restraints in Indonesia Clinical Laboratory Market
- Technological Advancements in Indonesia Clinical Laboratory Market
- Impact of COVID19 in Indonesia Clinical Laboratory Market
- Key Trends in Indonesia Clinical Laboratory Market
- Outlook and Future Projections for Indonesia Clinical Laboratory Market
- Recommendations / Success Factors
- Research Methodology
- Appendix
Products
Products
Key Segments Covered of Clinical Laboratory
- By Type of Labs
- Independent Labs
- Private Hospital Labs
- Public Hospital Labs
- By Number of Labs
- Private Labs
- Public Labs
- By Type of Private Independent Labs:
- Organised
- Unorganised
- By Type of payor:
- Corporates
- Out-Of-Pocket
- Private Insurance
- BPJS Badan Penyelenggara Jaminan Sosial (Social Insurance Administration Organization)
- By Type of Customer:
- Doctor Referral
- Corporates
- Walk-Ins
- External referrals
- Online Referrals
- By Type of Tests:
- Routine
- Esoteric
- Non-Laboratory
- By Type of routine tests:
- CBC
- Basic Metabolic Panel
- A1C
- Others
- ByType of Esoteric Tests
- Endocrine
- Infectious disease
- Allergic Disease
- Oncology
- Others
- By Private Hospital Labs
- In-HouseThird Party
- By Region
- Greater Jakarta
- West Java
- East Java, Bali, Nusa
- Aceh and North Sumatera
- Central Java
- Central Sumatera
- Sulawesi and Maluku
- Kalimantran
- Others
Key Target Audience
- Clinical Laboratory companies
- Organised Clinical Laboratories
- Unorganised Clinical Laboratories
- Private Hospitals
- Private Equity and Venture Capitalist
- Industry Associations
- Technology providers
Time Period Captured in the Report:
Historical Period – 2016-2021
Forecast Period – 2021-2026
Companies
Companies Covered:
Organised Laboratory Companies:
- Prodia
- Diagnos
- Pathlab
- Pramita
- Ultra Medica
- Kimia Farma
- Prima Medika
- Cito
- Parahita
- ABC Labs
- Bio Medika
Table of Contents
Table of Contents
1. Executive Summary
2. Industry Overview
2.1 Indonesia Country Profile
2.2 Indonesia Population Analysis
2.3 Indonesia Healthcare Overview
2.4 Health Infrastructure in Indonesia
2.5 Health Complaints and Outpatients in Indonesia
2.6 Indonesia Disease Statistics
2.7 Prevalence of Disease in Indonesia
2.8 Health Indicators of Indonesia
2.9 Health Infrastructure Gaps in Indonesia
3. Overview of Indonesia Clinical Laboratory Market
3.1 Snapshot of the Indonesian Clinical Laboratory Market
3.2 Hub and Spoke Business Model
3.3 Ecosystem of Major Entities in Indonesia Clinical Laboratory Market
3.4 Business Cycle and Genesis of Indonesia Clinical Laboratory Market
3.5 Timeline of Indonesia Clinical Laboratory Market
3.6 Evolution of Clinical Laboratory industry
3.7 Value Chain Analysis in Indonesia Clinical Laboratory Market
3.8 Robust Clinical Laboratory Industry
3.9 Customer Analysis of Indonesian Clinical Laboratory Market
4. IndonesiaClinical Laboratory Market Size, 2016-2021
4.1 Indonesia Clinical Laboratory Market Size, 2016-2021
4.2 Revenue Split by Type of Labs, 2017-2021
4.3 Number of Clinical Laboratories by Type of Region and by Type of Laboratories
4.4 By Type of Laboratory (Private and Public), 2021
5. Indonesia Clinical Laboratory Market Segmentation
5.1 Market Segmentation By Type of Independent Laboratory, 2021
5.2 Market Segmentation By Type of By Payer, 2021
5.3 Market Segmentation By Type of Customers, 2021
5.4 Market Segmentation By Type of Tests, 2021
5.5 Market Segmentation By Region, 2021
5.6 Market Segmentation By Type of Laboratory In Private Hospitals, 2021
6. IndustryAnalysis
6.1 SWOT Analysis of Indonesia Clinical Lab Market
6.2 Drivers of the Indonesia Clinical Laboratory Industry
6.3 Key Challenges in the Indonesia Clinical Laboratory Industry
6.4 Trends and Developments in the Indonesia Clinical Laboratory Industry
6.5 Technology Upgradations in the Indonesia Clinical Laboratory Industry
6.6 Government Regulations for Indonesia Clinical Laboratories Market
7. CompetitionScenario for Indonesia Clinical Laboratories Market
7.1 Competition Scenario for Indonesia Clinical Laboratories Market
7.2 Market Share of Major Organized Clinical Laboratories in Indonesia on the Basis of Revenues and Number of Labs, 2020
7.3 Company Profile/Competitive Landscape of Major Organized Diagnostics Labs in Indonesia (Company Overview, Regions, Lab Equipment Supplies, Third Party Tie-ups, Recent Developments, Future Plans, Number of Labs and Branches, Number of Tests Conducted, Revenue Per Visit, Best Selling Tests, Revenues in USD (2020 and 2021), Revenue Split by Type of Tests (2020), Revenue Split by Business Segment, 2020, Marketing Spent (2020)
7.4 Detailed Pricing Analysis for Each Type of Tests by Major Organized Laboratories in Indonesia
7.5 Case Study : Prodia
7.6 Case Study : Diagnos
8. FutureOutlook and Projections
8.1 Indonesia Clinical Laboratory Market Size, 2022-2026
8.2 Revenue Split by Type of Labs, 2026
8.3 Market Segmentation By Type of Tests, 2026
8.4 Area Of Testing to Capture the Biggest Untapped Market
8.5 Next Generation Laboratory Technology Trends
9. Impact of COVID-19
9.1 Impact of COVID-19 on Clinical Laboratory Market (Test & Prices) in Indonesia
9.2 Type of tests which were in Demand During COVID-19 and Post COVID-19
9.3 Response to COVID-19 Pandemic
10. Market Opportunity and Analyst Recommendation
10.1 Strategies to Tap the Opportunity
10.2 Comprehensive Service Offering with Proposed Marketing Strategy
10.3 Key Success factor for the Clinical Laboratory Players
10.4 Growth Strategy for the Indonesia Clinical Laboratory Industry
Research Methodology
Disclaimer
Contact US
You can also purchase parts of this report.
Do you want to check out a section wise price list?
Why Buy From US?
Refine Robust Result (RRR) Framework
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
Our Reach Is Unmatched
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
Shifting the Research Paradigm
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
More Insights-Better Decisions
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Transparency and Trust
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
Round the Clock Support
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.
Why Client Choose Us?
400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022